2 days ago

Senior Internal Auditor

Advanced Accelerator Applications

  • Work region
  • Sector
  • Employment type
  • Position

Advanced Accelerator Applications, a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy. AAA’s first theragnostic pairing for neuroendocrine tumors includes diagnostic drugs NETSPOT® in the US and SomaKit TOC® in Europe; and therapeutic Lutathera® (USAN: lutetium Lu 177 dotatate/INN: lutetium (177Lu) oxodotreotide). Additional theragnostics in development target gastrointestinal stromal tumors (GIST), and prostate and breast cancer. AAA is also an established leader in molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT, mainly used in clinical oncology, cardiology and neurology. Headquartered in Saint-Genis-Pouilly, France, AAA currently has 20 production and R&D facilities, and more than 600 employees in 13 countries (France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, The Netherlands, Belgium, Israel, the US and Canada). For more information, please visit: www.adacap.com.


 


AAA is looking for a Senior Internal Auditor to be based in Geneva and reporting to the Group Internal Audit Director. Working with the subsidiaries of AAA will require some travels to Europe and to the USA each quarter.

Senior Internal Auditor

Advanced Accelerator Applications, a Novartis company, is an innovative radiopharmaceutical company developing, producing and commercializing molecular nuclear medicine theragnostics. AAA’s theragnostic platform is based on radiolabeling a targeting molecule with either gallium Ga 68 for diagnostic use, or lutetium Lu 177 for therapy. AAA’s first theragnostic pairing for neuroendocrine tumors includes diagnostic drugs NETSPOT® in the US and SomaKit TOC® in Europe; and therapeutic Lutathera® (USAN: lutetium Lu 177 dotatate/INN: lutetium (177Lu) oxodotreotide). Additional theragnostics in development target gastrointestinal stromal tumors (GIST), and prostate and breast cancer. AAA is also an established leader in molecular nuclear diagnostic radiopharmaceuticals for PET and SPECT, mainly used in clinical oncology, cardiology and neurology. Headquartered in Saint-Genis-Pouilly, France, AAA currently has 20 production and R&D facilities, and more than 600 employees in 13 countries (France, Italy, the UK, Germany, Switzerland, Spain, Poland, Portugal, The Netherlands, Belgium, Israel, the US and Canada). For more information, please visit: www.adacap.com.


 


AAA is looking for a Senior Internal Auditor to be based in Geneva and reporting to the Group Internal Audit Director. Working with the subsidiaries of AAA will require some travels to Europe and to the USA each quarter.

Key tasks



  • Takes responsibilities in ensuring the compliance with Novartis Group and Sarbanes-Oxley requirements:




    • Documents and tests internal controls to ensure compliance with Sarbanes-Oxley; supports planning of gap remediation.




    • Assists and trains control owners in performing their controls.




    • Reviews testing documentation that is prepared by third party providers




  • Performs standard management and financial audits to identify exceptions to operating procedures and standards, ITGC and automatic controls audit, and develops specific solutions or recommendations.




  • Responsible for daily activities in support of and relating to the organization's Sarbanes Oxley compliance. Gathers data and creates reports documenting internal controls over financial reporting. May interact with external auditors as needed.




  • Executes special projects, including internal audit tasks, performs in-depth issue analyses and other duties as required and assigned.


    Professional skills and experience




  • At least 5 years of internal/external auditing experience, preferably in a Big 4 accounting firm and/or in the accounting, audit or compliance departments of a public company, preferably with SOX compliance responsibilities .




  • Demonstrated ability to multi task, to complete projects on time, and flexibility to adjust to changing priorities.




  • Strong analytical skills particularly in the assessment of the occurrence probability and impact of an internal control weakness.




  • Proficiency in risk analysis and report preparation.




  • Demonstrated ability and desire to learn quickly, be flexible and think strategically.




  • Ability to lead audits, manage projects and participate in audit assignments in a multi-cultural environment.




  • Knowledge of accounting standards (IFRS), auditing standards (PCAOB), computer systems, and general business operations.




  • Excellent communication (i.e., verbal and written) and interpersonal skills, with the ability to present complex and sensitive issues to senior management and influence change.




  • Willingness to travel




  • Fluency in English mandatory, French is highly appreciated, Italian and / or Spanish an asset.




  • Enthusiastic, self-motivated, autonomous, reliable, effective under pressure and willing to take personal responsibility/accountability.



4 rue de la Tour de l'Ile 1204 Genève